Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use TRIFERIC AVNU safely and effectively. See full prescribing information for TRIFERIC AVNU. TRIFERIC ®AVNU (ferric pyrophosphate citrate injection), for intravenous use Initial U.S. Approval: 2015
Medication labelWhy this: Advisory · dailymed-prescription
Triferic AVNU is an iron replacement product indicated for the replacement of iron to maintain hemoglobin in adult patients with hemodialysis-dependent chronic kidney disease (HDD-CKD). Limitations of Use Triferic AVNU is not intended for use in patients receiving peritoneal dialysis. Triferic AVNU has not been studied in patients receiving home hemodialysis.
- generic_name
- ferric pyrophosphate citrate
- product_names
- ferric pyrophosphate citrate
- ndc
- 57278-318, 57278-318-01, 57278-318-02, 57278-318-11
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en